{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "59572-775",
      "generic_name": "Luspatercept",
      "labeler_name": "Celgene Corporation",
      "brand_name": "Reblozyl",
      "active_ingredients": [
        {
          "name": "LUSPATERCEPT",
          "strength": "75 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "59572-775-01",
          "description": "1 VIAL, GLASS in 1 CARTON (59572-775-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
          "marketing_start_date": "20191108",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Celgene Corporation"
        ],
        "rxcui": [
          "2262906",
          "2262911",
          "2262913",
          "2262915"
        ],
        "spl_set_id": [
          "82f4d266-3f52-41eb-86ba-0abf3cf468e8"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000194025",
          "N0000009319"
        ],
        "pharm_class_epc": [
          "Erythroid Maturation Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Increased Erythroid Cell Production [PE]"
        ],
        "unii": [
          "AQK7UBA1LS"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "769ec39a-61bd-4726-b14a-9594897baa67",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20191108",
      "product_id": "59572-775_769ec39a-61bd-4726-b14a-9594897baa67",
      "application_number": "BLA761136",
      "brand_name_base": "Reblozyl",
      "pharm_class": [
        "Erythroid Maturation Agent [EPC]",
        "Increased Erythroid Cell Production [PE]"
      ]
    }
  ]
}